Formulation and evaluation of antifungal activity of Kasisadi Varti against Candida albicans
Keywords:Kasisadi varti, Antifungal activity, Candida albicans, Invitro study
Background: Medicine is said to be of good quality when it gives the desired therapeutic effect and at the same time does not cause any harm to the patients. The safety and efficacy of a medicine is of at most importance. Preclinical studies play a vital role in ascertaining the safety and efficacy of a drug before taking it for clinical trial. They mainly involve invitro and invivo models. Kasisadi churna is a formulation mentioned for external application in kaphaja yoni vyapath. Application of churna (powder) externally may not be compatible on patients, and hence the dosage form was modified into varti (suppository) form. Objective: Invitro study to asses antifungal activity of kasisadi varti. Material and Methods: Kasisadi varti were prepared in three different methods. They were assessed for activity against Candida albicans by invitro Agar well diffusion method at different concentrations 32mg/dl, 64mg/dl, 128mg/dl, 256mg/dl and 512 mg/dl. Result: All three samples showed significant activity against Candida albicans at a concentration of 128 mg/dl, 256mg/dl and 512mg/dl. Conclusion:All three samples showed significant results on Candida albicans developed from vaginal smears of patients at a concentration of 128mg/ml, 256mg/ml, and 512 mg/ml in comparison with standard drug Amphotericin B. None of the samples showed any effect on MTCC Strain of Candida albicans.
How to Cite
Copyright (c) 2022 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.